InfuSystem Holdings, Inc. (INFU) compared with its closest peers (OBIO, RCEL, EMBC, ANIK, OSUR): P/E 28.4 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | $325.77M | -3.7 |
| AVITA Medical, Inc. (RCEL) | $311.43M | -2.0 |
| Embecta Corp. (EMBC) | $309.93M | 3.5 |
| Anika Therapeutics, Inc. (ANIK) | $286.26M | -12.7 |
| OraSure Technologies, Inc. (OSUR) | $258.63M | -2.6 |
| Utah Medical Products, Inc. (UTMD) | $227.34M | 21.6 |
| Neuronetics, Inc. (STIM) | $215.03M | -2.3 |
| Pro-Dex, Inc. (PDEX) | $210.79M | 17.6 |
| Lucid Diagnostics Inc. (LUCD) | $195.15M | -1.6 |
| IceCure Medical Ltd (ICCM) | $179.15M | — |
| Stock P/E | 28.4 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 31.5% |
| vs Industry | -13.6% |
INFU overview · INFU earnings · INFU financials · INFU KPIs · INFU investor relations · INFU ownership · INFU filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.